Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Vincerx Pharma, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 55 | 65 | +10 |
| Shares | 15.4M | 16.3M | +888.1K (+5.8%) |
| Value | $156.8M | $65.1M | −$91.6M (−58.5%) |
New holders (14)
Institutions that held Vincerx Pharma, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 141,744 | $567.0K | 0.00% |
| Bank of Montreal | 84,131 | $332.0K | 0.00% |
| LMR Partners LLP | 51,200 | $205.0K | 0.00% |
| Trexquant Investment LP | 45,497 | $182.0K | 0.01% |
| Goldman Sachs Group Inc | 29,792 | $119.0K | 0.00% |
| Two Sigma Advisers, LP | 27,100 | $108.0K | 0.00% |
| Parametric Portfolio Associates LLC | 18,405 | $74.0K | 0.00% |
| Rhumbline Advisers | 13,307 | $53.0K | 0.00% |
| Susquehanna International Group, LLP | 13,094 | $52.0K | 0.00% |
| Jump Financial, LLC | 12,580 | $50.0K | 0.00% |
| Barclays PLC | 10,842 | $43.0K | 0.00% |
| Amalgamated Bank | 2,679 | $11.0K | 0.00% |
| Amalgamated Financial Corp. | 2,679 | $11.0K | 0.00% |
| FMR LLC | 459 | $2.00K | 0.00% |
Sold out (4)
Institutions that held Vincerx Pharma, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| RTW Investments, LP | 741,236 | $7.55M |
| Wellington Management Group LLP | 394,246 | $4.02M |
| Nan Fung Group Holdings Ltd | 11,050 | $113.0K |
| Point72 Hong Kong Ltd | 240 | $2.00K |